Jens Ersbøll

RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE

J Pedersen-Bjergaard, Severin Olesen Larsen, J. Struck et al. · The Lancet · 1987 · 222 citations

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +6

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-hodgkin's lymphomas

Nis I. Nissen, Jens Ersbøll, Hanne Sand Hansen et al. · Cancer · 2006 · 197 citations · Full text

Stage I-ii Non-hodgkin, Lymphoid Neoplasia, Surgical Oncology +15

Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma

J Pedersen-Bjergaard, Jens Ersbøll, V.L. Hansen et al. · New England Journal of Medicine · 1988 · 195 citations

Lymphoid Neoplasia, Urology, Surgical Oncology +10

Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.

J Pedersen-Bjergaard, Preben Philip, Larsen So et al. · PubMed · 1993 · 182 citations

Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma

Francesco Pezzella, Margaret T. Jones, Jens Ersbøll et al. · British Journal of Cancer · 1992 · 97 citations · Full text

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +9